A microbial fermentation composition subjected to enzymolysis, microbial fermentation and microbial transformation is prepared through extracting and hydrolyzing selected Edible and medicinal fungi Agaricus blazei, Lentinus edodes, Flammulina velutipes and ginseng of reinforcing vital energy, adding trace elements selenium, zinc and molybdenum, and fermenting and transforming by probiotics.

Disclosed herein are methods, systems, and compositions comprising genetically modified probiotic microorganisms. In some embodiments, the genetically modified probiotic microorganisms produce at least one viral coat protein and/or at least one fusion protein comprising an antigenic polypeptide linked to a viral coat protein.

A composition, containing a pepper component, a curcumin-cyclodextrin mixture and a mixture of fruits, vegetables and spices.

Animal nutrition compositions include a carrier and a fermentation product applied to the carrier. Liquid fermentation products are fluidly applied to dry carriers, such as phyllosilicates or other earthen components, while mixing and applying air flow, under appropriate temperature and pH conditions, to bind the fermentation product to the carrier and dry the reaction product to appropriate moisture content. Fermentation products are also mixed with liquid carriers, such as water. Fermentation products include components of a microbial fermentation culture, such as liquid medium, microbial cellular components, and fermentation metabolites produced by microorganisms. Some compositions include a pH buffering agent and/or additional components to further enhance beneficial effects of the composition, such as improved weight gain and feed conversion, reduced gut lesions, harmful gut bacteria count, and decreased mortality. Compositions can be mixed with animal feeds or otherwise administered. Compositions can inhibit fungal growth on animal feeds.

Disclosed herein is a process for producing a postbiotic extract, which includes providing a first material having a first isoelectric point ranging from pH 1 to pH 6 and a second material having a second isoelectric point ranging from pH 4 to pH 8, admixing the first material and a probiotic microorganism with water having a pH greater than the second isoelectric point, so as to form a mixture, adding the second material into the mixture and then adjusting a pH of the second material-added mixture to between the first and second isoelectric points so that a precipitate is formed, and subjecting the precipitate to a cell wall isolation treatment to obtain the postbiotic extract. Use of the postbiotic extract is also disclosed.

A freeze-dried nipa palm powder obtainted by mixing (75-100) part of a sap of inflorescence stalk with (0-25) part other ingredients, then freezing said sap of inflorescence stalk with said other ingredients in frozen molds using an individual quick freezer (IQF) at temperature from −25° C. to −29° C. to obtain frozen sap of inflorescence stalk blocks, and freeze drying frozen sap of inflorescence stalk molds at a pressure of 7.8948×10.sup.−4−1.3158×10.sup.−3 atm for 48 hours. The freeze-dried nipa palm powder such as multi-purpose food products that can be used not only as directly, or dissolved in water such as a beverage, but also as a health-promoting functional food, improve immunity, skin care, and beauty for users.

A simple cellulose sulphate based microencapsulation technology has been applied to encapsulate bacterial or other microbial cells, which produce and release digestive enzymes and thereby provides an acid resistant shelter for these microbial cells. Surprisingly, the resulting spheres were found to provide sufficient protection for encapsulated cells from treatment with aqueous acidic solutions. Thereby the cellulose sulphate microencapsulated cells, such as probiotics are now enabled to survive passage, for example, through the stomach after consumption by a human or animal with a higher survival rate than those not within a microcapsule. After passing the stomach these cells are delivering products produced by them, e.g. enzymes or other nutrition factors. This technology therefore proves to be very useful in providing digestive or otherwise beneficial enzymes and/or of living microbial cells, into the lower gastrointestinal tract, where they could confer their health benefit to the host.

A delayed-release composition composed of a Lactobacillus bacterium, Bifidobacterium longum, Streptococcus thermophlus, inulin and xylooligosaccharide is provided for use in reducing nitrogenous waste products in the blood and treating renal failure.

A probiotic for inhibiting and preventing the progression of a renal disease and a composition containing the same are disclosed. The probiotic contains a novel Lactobacillus acidophilus BP105 strain, a novel Lactobacillus salivarius BP121 strain. The novel probiotics, the Lactobacillus acidophilus BP105 strain and the Lactobacillus salivarius BP121 strain exhibit excellent indoxyl sulfate removal ability, p-cresol removal ability, and phosphorus absorption ability.

The present invention relates to a method for extracting and purifying pea proteins, comprising the steps of (a) providing an aqueous composition comprising pea proteins; (b) isolating said pea proteins from said aqueous composition comprising pea proteins; (c) obtaining said isolated pea proteins as an aqueous slurry having a pH ranging from 4.0 to 5.8; and (d) subjecting said aqueous slurry having a pH ranging from 4.0 to 5.8 to a temperature of at least 75° C. Also described herein are pea protein compositions and are food or feed products comprising said pea protein compositions.